Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03384173 · ClinicalTrials.gov registry record
NIRS Monitoring to Detect AKI in Preterm Infants
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 35
- Enrollment target
NCT03384173: Completed study, sponsored by University of Wisconsin, Madison.
NCT03384173 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03384173 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
This study will examine the relationship of oxygen levels, using Near-infrared spectroscopy (NIRS) monitoring, and kidney injury in infants born prematurely. NIRS is a skin sensor which detects the amount of oxygen going to different organs, most often used to monitor the brain and kidney.
Primary Outcome
Comparison of Renal saturation (Rsat) in neonates with AKI to those without AKI. RSO2 will be recorded until 7 days of age. Median RSO2 for 1 week and median for individual days 2-7 will be calculated. The INVOS 5100 C (Somanetics, Troy, MI, USA) four channel NIRS monitors will be used to measure renal regional oxygenation (RrSO2) values for all neonates.
Interventions
- DEVICE Near Infrared Spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2018-04-25 |
| Est. Completion | 2019-12-31 |
What the finished NCT03384173 record still lists
NCT03384173 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Near Infrared Spectroscopy is the first listed.
NCT03384173 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03384173 about?
NCT03384173 is a clinical study titled "NIRS Monitoring to Detect AKI in Preterm Infants". This study will examine the relationship of oxygen levels, using Near-infrared spectroscopy (NIRS) monitoring, and kidney injury in infants born prematurely. NIRS is a skin sensor which detects the amount of oxygen going to different organs, most often used to monitor the brain and kidney.
What is the current status of trial NCT03384173?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2018-04-25. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03384173?
The interventions under investigation include: Near Infrared Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT03384173?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI